-
성명
박선영
-
연구분야
In vitro diagnostics, Exosomes
-
연구실
의생명과학관 A-213
- 연락처
- 이메일
- 홈페이지
학력
학사: 연세대학교 임상병리학과 2009.03-2013.02
석박사통합: 연세대학교 임상병리학과 2013.03-2019.02
주요경력
박사후과정: 연세대학교 기계공학과 2019.03-2021.01
연구교수: 연세대학교 기계공학과 2021.02-2025.08
연구소장: 더다봄 기업부설연구소 2022.10-2025.02
주요연구실적
- Postbiotic-assisted synthesis of cerium oxide nanocomposites functionalized with folic acid-chitosan and tea polyphenols for redox-regulated anticancer activity. Internatioanl Journal of Biological Macromolecules (2026). (IF 8.5). Corresponding author
- Automated multi-diagnostic platform for respiratory viruses using integrated microfluidic cartridge and RT-RPA/CRISPR detection. Sensors and Actuators B: Chemical (2026). (IF 7.7). First author
- Microfluidic Generation of Exosome-Mimetic Nanoparticles for Scalable Production and Enhanced Therapeutic Efficacy. Small (2025). (IF 12.1). Corresponding author
- Microfludic ExoBONE assay for Predicting Bone Mineral Density Improvement in Primary Hyperparathyroidism. Biochip Journal (2025). (IF 6.1). First autor
- Machine Learning-Driven Microfluidic Deglycosylation for Ultra-Sensitive Detection of PD-L1 Extracellular Vesicles. Sensors and Actuators B: Chemical (2025). (IF 7.7). First author
- CD9-enriched extracelluarl vesicles from chemically reprogrammed basal progenitors of salivary mitigate salivary gland fibrosis. Bioactive Materials (2025). (IF 20.3). First author
- An all-in-one platform to deplete pathogenic bacteria for rapid and safe enrichment of plant-derived extracellular vesicles. Lab on a Chip (2023). (IF 6.1). Corresponding author
- Continuous Isolation of Stem-Cell-Derived Extracellular Vesicles (SC-EVs) by Recycled Magnetic Beads in Microfluidic Channels. BioChip Journal (2023). (IF 5.5). Corresponding author
- Microfluidic chip for rapid and selective isolation of tumor-derived extracellular vesicles for early diagnosis and metastatic risk evaluation of breast cancer. Biosensors and Bioelectronics (2021). (IF 12.545). First autor
- miR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer (2017). (Cited 168). First autor